2012-09-17 06:03:27 - Recently published research from Global Markets Direct, "Fina Biotech - Product Pipeline Review - 2012", is now available at Fast Market Research

Global Markets Direct's pharmaceuticals report, "Fina Biotech - Product Pipeline Review - 2012" provides data on the Fina Biotech's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Fina Biotech's corporate website, SEC filings, investor presentations and featured press releases, both from Fina Biotech and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Fina Biotech - Brief Fina Biotech overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Fina Biotech human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Fina Biotech with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Fina Biotech's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463683_fina_biotech_product_pipeline_review_ ..


Reasons to buy

* Evaluate Fina Biotech's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Fina Biotech in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Fina Biotech's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Fina Biotech.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Fina Biotech and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Fina Biotech; Fina Biotech - Key Therapeutics; Fina Biotech - Pipeline Overview and Promising Molecules; Fina Biotech - News; Fina Biotech - Latest Updates; Fina Biotech - Pipeline; Fina Biotech - Discontinued/Dormant Projects

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Fina Biotech Snapshot
Fina Biotech Overview
Key Information
Key Facts
Fina Biotech - Research and Development Overview
Key Therapeutic Areas
Fina Biotech - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Fina Biotech - Pipeline Products Glance
Fina Biotech Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Fina Biotech - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Fina Biotech - Drug Profiles
Cell Therapy For Stroke
Product Description
Mechanism of Action
R&D Progress
FB 1003
Product Description
Mechanism of Action
R&D Progress
FB 1004
Product Description
Mechanism of Action
R&D Progress
FB 2001
Product Description
Mechanism of Action
R&D Progress
Percutaneous Implantation Of Autologous Myoblasts
Product Description
Mechanism of Action
R&D Progress
Fina Biotech - Pipeline Analysis
Fina Biotech - Pipeline Products by Therapeutic Class
Fina Biotech - Pipeline Products by Route of Administration
Fina Biotech - Dormant Projects
Fina Biotech - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Fina Biotech, Key Information
Fina Biotech, Key Facts
Fina Biotech - Pipeline by Indication, 2012
Fina Biotech - Pipeline by Stage of Development, 2012
Fina Biotech - Monotherapy Products in Pipeline, 2012
Fina Biotech - Phase II, 2012
Fina Biotech - Pre-Clinical, 2012
Fina Biotech - Pipeline By Therapeutic Class, 2012
Fina Biotech - Pipeline By Route of Administration, 2012
Fina Biotech - Dormant Developmental Projects,2012

List of Figures
Fina Biotech - Pipeline by Indication, 2012
Fina Biotech - Pipeline by Stage of Development, 2012
Fina Biotech - Monotherapy Products in Pipeline, 2012
Fina Biotech - Pipeline By Therapeutic Class, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.